Arlene Quintyne

Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 08 Mar 2016 for Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation).

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Our data holds just one disclosure by Arlene Quintyne, dated 8 March 2016, reporting a transaction in Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation). Further filings will be added here. Source: insider filings from SEDI. Past trades are no guide to future returns.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

●

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives31 Dec 2015Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)

0SEDI

Common SharesTSXSEDI:2800608

1 of 1 declaration